Clinical Trials
2 trialsNCT07022301 2025-06-15
Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy
First Affiliated Hospital of Wannan Medical College
Phase 2 Not yet recruiting
NCT06851819 2025-02-28
TERE
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting